ETAILS Medanta, DLF To Launch 400-Bed Hospital In South Delhi

New Delhi : Global Health Limited will launch a 400-bed multi-super specialty hospital in Delhi in association with real estate developer DLF, the private healthcare provider said on Thursday.

The super speciality hospital is slated to provide cutting-edge medical and surgical interventions in over 20 super specialties, including Cardiac sciences, Neurosciences, Orthopaedics, Kidney, Liver, Lung and Heart Transplants, Gastroenterology, and Chest Surgery, the company said in a statement.

The facility will also have a Comprehensive Cancer Care unit, offering end-to-end oncology treatments under one roof. This new facility will strengthen Medanta’s presence in the National Capital Region of Delhi. Medanta will operate its Gurugram, Noida, and Delhi facilities in a seamless manner linking its existing 1,391-bed flagship hospital in Gurugram and its upcoming Noida facility (550 beds) to the new hospital in South Delhi.

“Our new hospital will bring the best of Medanta’s renowned clinical expertise and patient care closer to the people of Delhi. It will offer cutting-edge surgical treatments across specialties under one roof with the same patient quality safety standards that Medanta has come to be known for. It will also become a one-stop solution for all types of cancer treatments and will benefit a large swathe of patients not only in Delhi but across Uttar Pradesh, Haryana, Rajasthan, and other neighbouring states,” Dr. Naresh Trehan, Chairman and Managing Director of Global Health Limited, said.

Both Medanta and DLF will hold equal 50% equity in the new company, which is set to inaugurate the upcoming hospital in Greater Kailash (GK), South Delhi. DLF will serve as a strategic investor, while Medanta will assume operational control of the hospital, as stated by Global Health Limited in a regulatory filing.

“The new hospital will strengthen the medical infrastructure in Delhi and further strengthen DLF’s deep commitment to improving the quality of life for NCR residents,” Rajiv Singh, Chairman of DLF Ltd said.

Related Posts

IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

GUWAHATI: Indian Institute of Technology Guwahati researchers have developed an optical sensing device that can instantly detect a variety of toxicants in water and other biological samples. Aligned with the Government…

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

New Delhi: The Centre has disclosed a significant enforcement action against hospitals found violating the guidelines of the Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), with 2,359 hospitals de-empanelled, 1,200…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

NHS backs delayed‑release treatment for cystinosis

NHS backs delayed‑release treatment for cystinosis

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad